Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients
This phase I multicenter study was aimed at assessing the feasibility and safety of intravenous administration of third party bone marrow-derived mesenchymal stromal cells (MSC) expanded in platelet lysate in 40 patients (15 children and 25 adults), experiencing steroid-resistant grade II to IV graf...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
语言: | 英语 |
出版: |
2013
|
在线阅读: | https://doi.org/10.1016/j.bbmt.2013.11.033 |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|